Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361589
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-03-26
Brief Title:
Real World Study of Lolatinib for Advanced ALK NSCLC Patients
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Sichuan Cancer Hospital and Research Institute
Organization Data
Organization:
Sichuan Cancer Hospital and Research Institute
Class:
OTHER
Study ID:
EK2023003-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Juan LI MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan Cancer Hospital and Research Institute
Old Name:
None
Old Organization:
None